| Literature DB >> 28727383 |
Eyyup Sabri Pelit1, Bülent Kati1, Cengiz Çanakci2, Süleyman Sağir1, Halil Çiftçi1.
Abstract
OBJECTIVES: The present study was aim to evaluate the safety and efficacy of Mini-PNL to treat kidney stones in patients aged <3 years. This is the one of the largest series in the literature in this age group of patients.Entities:
Keywords: Infant; Kidney Calculi; Nephrostomy, Percutaneous
Mesh:
Year: 2017 PMID: 28727383 PMCID: PMC5678527 DOI: 10.1590/S1677-5538.IBJU.2016.0629
Source DB: PubMed Journal: Int Braz J Urol ISSN: 1677-5538 Impact factor: 1.541
Patients’ demographics and preoperative data.
| Age of patients (months) | 21.5±8.2 (10-36) | |
|---|---|---|
| Male/Female | 42/30 (58.3% / 41.7%) | |
|
| 22±5.9 (14-45) | |
| <20 mm | 49 (68.1%) | |
| >20 mm | 23 (31.9%) | |
|
| ||
| Renal pelvis | 20 (27.8%) | |
| Lower pole | 17 (23.6%) | |
| Middle pole/Upper pole | 11 (15.3%) | |
| Partial/complete | 24 (33.3%) | |
| staghorn | ||
| Laterality L/R | 41/31 | |
|
| ||
| Grade 0 | 12 (16.6%) | |
| Grade 1 | 15 (20.8%) | |
| Grade 2 | 37 (51.4%) | |
| Grade 3 | 8 (11.2%) | |
Factors that affect the stone free status of the patients.
| Initional stone-free status (84.7%) | Residual stone without additional treatment (15.3%) | P value | ||
|---|---|---|---|---|
|
| 0.820 | |||
| Male | 36 (59.1%) | 6 (54.5%) | ||
| Female | 25 (40.9%) | 5 (45.5%) | ||
|
| 0.223 | |||
| Right side | 27 (44.2%) | 4 (36.3%) | ||
| Left side | 34 (55.8%) | 7 (63.7%) | ||
| Stone size (mm) | 15±4.2 | 22±4.9 |
| |
|
|
| |||
| Renal pelvis or single calyx | 45 (73.7%) | 3 (27.2%) | ||
| Partial/complete staghorn | 16 (26.3%) | 8 (72.8%) | ||
|
| 0.065 | |||
| Grade 0-1 | 22 (36.1%) | 5 (45.4) | ||
| Grade 2-3 | 39 (63.9%) | 6 (54.6) | ||
Intraoperative data.
| Puncture location | ||
|---|---|---|
| Subcostal | 67(93.1%) | |
| Supracostal | 5 (6.9%) | |
|
| ||
| Single | 68 (94.4%) | |
| Multiple | 4 (5.6%) | |
| Operative time (mean mins) | 69 (40-140) | |
| Hospitalization time (mean days) | 3 (2-9) | |
| Fluoroscopic screening time (mean mins) | 3.6(1.2-9.8) | |
| Tubeless PNL | 6 (8.4%) | |
| Tube PNL | 66(91.6%) | |
Postoperative data.
| Initial Stone free rate(after 1 month) | 61 (84.7%) | |
|---|---|---|
| Stone free rate after additional therapy | 68(94.4%) | |
|
| ||
| ESWL | 7 | |
| Re-PNL | 3 | |
| URS | 1 | |
| Minor (Clavien I-II) complications | 14 (19.4%) | |
| Major (Clavien III-V) complications | 1 (1.3%) | |
| Preoperative hemoglobin level | 12.3 (9.8-15.3) | |
| Postoperative hemoglobin level | 11.3 (8.9-13.9) | |
|
| ||
| Uric acid | 9 (12.5%) | |
| Cystine | 11 (15.3%) | |
| CaOx-CaP | 16 (22.3%) | |
| Struvite | 7 (9.7%) | |
| Unknown | 29 (40.2%) | |